Product Program year 2025 Source: CMS Open Payments

RiaSTAP

Biological Hematology

NDC 63833-891-51

Open in the dashboard

General payments

$124,876

98 payments

Research payments

$1,299

1 payment

Through program year 2025, $124,876 in general payments and $1,299 in research payments were reported against RiaSTAP (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $99,548 79
2024 General $878 1
2023 General $555 2
2021 General $4,271 5
2020 General $19,623 11
2020 Research $1,299 1

Breakdown

Who paid General payments · program years 2020–2025
  1. CSL Behring $124,876 98 payments
Top recipients General payments · program year 2025
  1. Melissa Cushing Clinical Pathology/Laboratory Medicine · New York, NY $19,135 19% · 11 payments
  2. David Faraoni Pediatric Anesthesiology · Boston, MA $15,106 15% · 2 payments
  3. Daniel Katz Anesthesiology · New York, NY $10,219 10% · 10 payments
  4. John Kowalczyk Anesthesiology · Boston, MA $8,446 8% · 11 payments
  5. Jonathan Waters Pittsburgh, PA $8,116 8% · 9 payments

The top 5 of 12 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Anesthesiology $44,308 48% · 7 practitioners
  2. Clinical Pathology/Laboratory Medicine Pathology $19,135 21% · 1 practitioner
  3. Pediatric Anesthesiology Anesthesiology $15,106 17% · 1 practitioner
  4. Surgery $7,657 8% · 1 practitioner
  5. Blood Banking & Transfusion Medicine Pathology $5,226 6% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. New York $40,781 41% · 4 recipients
  2. Massachusetts $23,552 24% · 2 recipients
  3. Pennsylvania $15,773 16% · 2 recipients
  4. New Jersey $7,207 7% · 1 recipient
  5. Georgia $6,836 7% · 2 recipients

The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

98 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record